FR2103608A1 - - Google Patents

Info

Publication number
FR2103608A1
FR2103608A1 FR7131004A FR7131004A FR2103608A1 FR 2103608 A1 FR2103608 A1 FR 2103608A1 FR 7131004 A FR7131004 A FR 7131004A FR 7131004 A FR7131004 A FR 7131004A FR 2103608 A1 FR2103608 A1 FR 2103608A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7131004A
Other languages
French (fr)
Other versions
FR2103608B1 (el
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Philips Gloeilampenfabrieken NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philips Gloeilampenfabrieken NV filed Critical Philips Gloeilampenfabrieken NV
Publication of FR2103608A1 publication Critical patent/FR2103608A1/fr
Application granted granted Critical
Publication of FR2103608B1 publication Critical patent/FR2103608B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR7131004A 1970-08-29 1971-08-26 Expired FR2103608B1 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7012832A NL7012832A (el) 1970-08-29 1970-08-29

Publications (2)

Publication Number Publication Date
FR2103608A1 true FR2103608A1 (el) 1972-04-14
FR2103608B1 FR2103608B1 (el) 1975-02-07

Family

ID=19810895

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7131004A Expired FR2103608B1 (el) 1970-08-29 1971-08-26

Country Status (7)

Country Link
US (1) US3755557A (el)
BE (1) BE771918A (el)
CA (1) CA971480A (el)
DE (1) DE2141289A1 (el)
FR (1) FR2103608B1 (el)
GB (1) GB1302671A (el)
NL (1) NL7012832A (el)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2423217A2 (fr) * 1978-03-10 1979-11-16 Anvar Procede de vaccination contre la myxomatose

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
US4223014A (en) * 1978-05-08 1980-09-16 The United States Of America As Represented By The Secretary Of The Interior Spray immunization of fish
EP0009277B1 (en) * 1978-09-14 1984-04-18 Gist-Brocades N.V. Combined vaccine active against newcastle disease and egg production drop caused by adeno-like viruses, process for preparing it, adeno-like and newcastle disease virus strains
US4225583A (en) * 1978-12-07 1980-09-30 Iowa State University Research Foundation, Inc. Intra-respiratory vaccine for prevention of Bordetella bronchiseptica infection and method of use
NL7812359A (nl) * 1978-12-20 1980-06-24 Gist Brocades Nv Vaccins tegen door reo virus veroorzaakte ziektever- schijnselen en werkwijze voor het bereiden van deze vaccins.
NL8102786A (nl) * 1981-06-10 1983-01-03 Duphar Int Res Werkwijze voor het immuniseren van varkens tegen de ziekte van aujeszky.
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
DE3686025T2 (de) * 1985-05-22 1993-01-07 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
CA2097830C (en) * 1990-12-04 2000-02-01 Stephen G. Newman Spray-dried antigenic products and method of preparation
AU709262B2 (en) * 1995-10-17 1999-08-26 Board Of Regents, The University Of Texas System Insoluble drug delivery
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
US7255877B2 (en) * 1996-08-22 2007-08-14 Jagotec Ag Fenofibrate microparticles
WO1999040906A2 (en) * 1998-02-11 1999-08-19 Research Triangle Pharmaceuticals Method and composition for treatment of inflammatory conditions
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
ATE259220T1 (de) 1998-05-29 2004-02-15 Skyepharma Canada Inc Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
US7097849B2 (en) 1998-08-19 2006-08-29 Jagotec Ag Injectable aqueous dispersions of propofol
RU2233654C2 (ru) 1998-11-20 2004-08-10 Ртп Фарма Инк. Диспергируемые стабилизированные фосфолипидом микрочастицы
IL148685A0 (en) * 1999-09-21 2002-09-12 Rtp Pharma Inc Surface modified particulate compositions of biologically active substances
ES2469642T3 (es) 2000-04-20 2014-06-18 Jagotec Ag Procedimiento mejorado para partículas de fármaco insoluble en agua
US6634576B2 (en) 2000-08-31 2003-10-21 Rtp Pharma Inc. Milled particles
US8586094B2 (en) 2000-09-20 2013-11-19 Jagotec Ag Coated tablets
WO2002067901A1 (en) * 2001-02-22 2002-09-06 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
CN1607941A (zh) * 2001-11-19 2005-04-20 贝克顿迪肯森公司 粒状药物组合物
DE60336588D1 (de) * 2003-02-13 2011-05-12 Dickinson And Co Verbesserte anthraximpfstoffe und abgabeverfahren
EP2485764A4 (en) * 2009-10-09 2014-01-29 Childrens Medical Center WHOLE CELL VACCINE WITH SELECTIVE DISSOCIATION
CN103386125A (zh) * 2012-05-08 2013-11-13 刘江秋 肾综合征出血热鼻黏膜免疫气溶胶疫苗的研制
CN107475204A (zh) * 2017-08-03 2017-12-15 中国人民解放军军事医学科学院军事兽医研究所 一种囊膜病毒保护剂及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2423217A2 (fr) * 1978-03-10 1979-11-16 Anvar Procede de vaccination contre la myxomatose

Also Published As

Publication number Publication date
BE771918A (fr) 1972-02-28
GB1302671A (el) 1973-01-10
DE2141289A1 (de) 1972-03-09
NL7012832A (el) 1972-03-02
CA971480A (en) 1975-07-22
US3755557A (en) 1973-08-28
FR2103608B1 (el) 1975-02-07

Similar Documents

Publication Publication Date Title
FR2103608B1 (el)
AR204384A1 (el)
ATA96471A (el)
AU1146470A (el)
AU1473870A (el)
AU1326870A (el)
AU1716970A (el)
AU1336970A (el)
AU2085370A (el)
AU1833270A (el)
AR195465A1 (el)
AU1086670A (el)
AU2131570A (el)
AU1064870A (el)
AU1083170A (el)
AU1943370A (el)
AU1591370A (el)
AU2130770A (el)
AU1918570A (el)
AU1189670A (el)
AU1581370A (el)
AU1881070A (el)
AU1841070A (el)
AU2144270A (el)
AU1789870A (el)

Legal Events

Date Code Title Description
TP Transmission of property